Shares of Cadence Pharmaceuticals (CADX +12.0%) jump on news that the company will resubmit its...

|By:, SA News Editor

Shares of Cadence Pharmaceuticals (CADX +12.0%) jump on news that the company will resubmit its market application for U.S. approval of its acetaminophen intravenous formulation within 30 days. (PR)